ASH 2018 | Cellular therapies for NHL: current challenges and perspectives

Ian Flinn

Speaking the American Society of Hematology (ASH) 2018 Annual Meeting and Exposition, held in San Diego, CA, Ian Flinn, MD, PhD, of the Tennessee Oncology, Nashville, TN, discusses his perspective on the promise and challenges of cellular therapy. Dr Flinn highlights the need to continue investigating other immunotherapy and small molecular options, rather than focusing solely on one therapy type.

Share this video